Background: Most commercially available automated insulin delivery (AID) systems are not approved for pregnancy use. Information regarding use of the Tandem t:slim X2 insulin pump with Control-IQ™ technology in pregnancy is lacking.
Aims: This case series aimed to explore glycaemic and qualitative experiences of four early adopters of Control-IQ technology in pregnancy.